Scientists from startup 23andMe have begun a study of the disease COVID-19. As part of their study, doctors will analyze how genetics can affect differences in the severity of this disease in humans. This was said in a statement.
Already, scientists can definitely say that age, chronic diseases and the general state of human health greatly affect the severity of coronavirus infection. It is well known that genetics affects how people get sick with other types of infectious diseases, but today the role of genes in the distribution of COVID-19 is unknown.
23andMe opened its platform for registering volunteers to participate in a study of the effects of COVID-19 on the body depending on genetics. The company hopes that among the people who agree to provide their data, there will be both people with a confirmed diagnosis of COVID-19 and people with negative tests.
The study will be conducted using online surveys. At the same time, all study participants must undergo several such surveys – once a month.
Thanks to his research, 23andMe will be able to find genetic variants that are more susceptible to the disease, as well as types of genes that are prone to severe COVID-19.